147 related articles for article (PubMed ID: 29489092)
1. In vitro skin models in the optimization of skin formulations.
Bakonyi M; Berkó S; Budai-Szücs M; KovÁcs A; Spaits T; Samu G; Csanyi E
Acta Pharm Hung; 2017; 87(1):3-12. PubMed ID: 29489092
[TBL] [Abstract][Full Text] [Related]
2. In vitro skin models as a tool in optimization of drug formulation.
Flaten GE; Palac Z; Engesland A; Filipović-Grčić J; Vanić Ž; Škalko-Basnet N
Eur J Pharm Sci; 2015 Jul; 75():10-24. PubMed ID: 25746955
[TBL] [Abstract][Full Text] [Related]
3. Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment.
Manosroi A; Chankhampan C; Manosroi W; Manosroi J
Eur J Pharm Sci; 2013 Feb; 48(3):474-83. PubMed ID: 23266464
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
5. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
[TBL] [Abstract][Full Text] [Related]
6. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
7. Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation.
Wenande E; Anderson RR; Haedersdal M
Adv Drug Deliv Rev; 2020 Jan; 153():169-184. PubMed ID: 31628965
[TBL] [Abstract][Full Text] [Related]
8. Formulation design for topical drug and nanoparticle treatment of skin disease.
Raphael AP; Garrastazu G; Sonvico F; Prow TW
Ther Deliv; 2015 Feb; 6(2):197-216. PubMed ID: 25690087
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration.
Engesland A; Škalko-Basnet N; Flaten GE
J Pharm Sci; 2015 Mar; 104(3):1119-27. PubMed ID: 25558045
[TBL] [Abstract][Full Text] [Related]
10. Carriers in the topical treatment of skin disease.
Korting HC; Schäfer-Korting M
Handb Exp Pharmacol; 2010; (197):435-68. PubMed ID: 20217539
[TBL] [Abstract][Full Text] [Related]
11. Topical delivery of active principles: the field of dermatological research.
Nino M; Calabrò G; Santoianni P
Dermatol Online J; 2010 Jan; 16(1):4. PubMed ID: 20137746
[TBL] [Abstract][Full Text] [Related]
12. [Significance of topical therapy in clinical situations. Location-dependent principles].
von Stebut E
Hautarzt; 2014 Mar; 65(3):186-91. PubMed ID: 24419475
[TBL] [Abstract][Full Text] [Related]
13. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
14. Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.
Lam PL; Gambari R
J Control Release; 2014 Mar; 178():25-45. PubMed ID: 24417967
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
Tashtoush BM; Bennamani AN; Al-Taani BM
Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
[TBL] [Abstract][Full Text] [Related]
16. Imaging and quantifying drug delivery in skin - Part 1: Autoradiography and mass spectrometry imaging.
Grégoire S; Luengo GS; Hallegot P; Pena AM; Chen X; Bornschlögl T; Chan KF; Pence I; Obeidy P; Feizpour A; Jeong S; Evans CL
Adv Drug Deliv Rev; 2020 Jan; 153():137-146. PubMed ID: 31778729
[TBL] [Abstract][Full Text] [Related]
17. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
Godin B; Touitou E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
[TBL] [Abstract][Full Text] [Related]
18. In vitro methods for screening transdermal formulations.
Tsai PC; Lee S; Michniak-Kohn B
Ther Deliv; 2015; 6(9):1043-52. PubMed ID: 26419344
[TBL] [Abstract][Full Text] [Related]
19. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
20. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
